Evidence map›Paper›PMID 30907498›Full record

ArticleJournal of the International AIDS Society2019

The impact and cost-effectiveness of community-based HIV self-testing in sub-Saharan Africa: a health economic and modelling analysis.

Valentina Cambiano, Cheryl C Johnson, Karin Hatzold, Fern Terris-Prestholt, Hendy Maheswaran, Harsha Thirumurthy, Carmen Figueroa, Frances M Cowan, Euphemia L Sibanda, Getrude Ncube and 5 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Evidence Gaps in Economic Evaluations of HIV Interventions Targeting Young People: A Systematic Review.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Valentina CambianoInstitute for Global Health, University College London, London, United Kingdom.
Cheryl C JohnsonWorld Health Organization, Geneva, Switzerland.
Karin HatzoldPopulation Services International, Washington, DC, USA.
Fern Terris-PrestholtDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Hendy MaheswaranInstitute of Psychology, Health and Society, University of Liverpool, Liverpool, United Kingdom.
Harsha ThirumurthyDepartment of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Carmen FigueroaWorld Health Organization, Geneva, Switzerland.
Frances M CowanCentre for Sexual Health and HIV AIDS Research (CeSHHAR), Harare, Zimbabwe.
Euphemia L SibandaCentre for Sexual Health and HIV AIDS Research (CeSHHAR), Harare, Zimbabwe.
Getrude NcubeZimbabwe Ministry of Health and Child Care, Harare, Zimbabwe.
Paul RevillCentre for Health Economics, University of York, York, United Kingdom.
Rachel C BaggaleyWorld Health Organization, Geneva, Switzerland.
Elizabeth L CorbettMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Andrew PhillipsInstitute for Global Health, University College London, London, United Kingdom.
for Working Group on Cost Effectiveness of HIV self-testing in Southern Africa

Funding

UnitaidWellcome Trust 200901/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

introductionThe prevalence of undiagnosed HIV is declining in Africa, and various HIV testing approaches are finding lower positivity rates. In this context, the epidemiological impact and cost-effectiveness of community-based HIV self-testing (CB-HIVST) is unclear. We aimed to assess this in different sub-populations and across scenarios characterized by different adult HIV prevalence and antiretroviral treatment programmes in sub-Saharan Africa.

methodsThe synthesis model was used to address this aim. Three sub-populations were considered for CB-HIVST: (i) women having transactional sex (WTS); (ii) young people (15 to 24 years); and (iii) adult men (25 to 49 years). We assumed uptake of CB-HIVST similar to that reported in epidemiological studies (base case), or assumed people use CB-HIVST only if exposed to risk (condomless sex) since last HIV test. We also considered a five-year time-limited CB-HIVST programme. Cost-effectiveness was defined by an incremental cost-effectiveness ratio (ICER; cost-per-disability-adjusted life-year (DALY) averted) below US$500 over a time horizon of 50 years. The efficiency of targeted CB-HIVST was evaluated using the number of additional tests per infection or death averted.

resultsIn the base case, targeting adult men with CB-HIVST offered the greatest impact, averting 1500 HIV infections and 520 deaths per year in the context of a simulated country with nine million adults, and impact could be enhanced by linkage to voluntary medical male circumcision (VMMC). However, the approach was only cost-effective if the programme was limited to five years or the undiagnosed prevalence was above 3%. CB-HIVST to WTS was the most cost-effective. The main drivers of cost-effectiveness were the cost of CB-HIVST and the prevalence of undiagnosed HIV. All other CB-HIVST scenarios had an ICER above US$500 per DALY averted.

conclusionsCB-HIVST showed an important epidemiological impact. To maximize population health within a fixed budget, CB-HIVST needs to be targeted on the basis of the prevalence of undiagnosed HIV, sub-population and the overall costs of delivering this testing modality. Linkage to VMMC enhances its cost-effectiveness.

Indexed as

Cost-Benefit AnalysisAdolescentAdultAfrica South of the SaharaAnti-Retroviral AgentsCircumcision, MaleFemaleHIV InfectionsHumansMaleMass ScreeningMiddle AgedQuality-Adjusted Life YearsSerologic TestsYoung AdultAnti-Retroviral Agentsbenefits and costcost-effectivenessHIVHIV testing, community-based HIV self-testingmathematical modelling

Identifiers

PMID30907498
PMCPMC6432108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.